JP Morgan Chase
BIOC

JP Morgan Chase’s Biocept, Inc. BIOC Stock Holding History

JP Morgan Chase’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-268
Closed -$324 – 7899
2023
Q2 		$324 Buy
+268
New +$1.52K ﹤0.01% 6584
2022
Q2 		– Sell
-2,712
Closed -$189K – 7086
2022
Q1 		$189K Sell
2,712
-81
-3% -$6.36K ﹤0.01% 5225
2021
Q4 		$303K Buy
2,793
+2,273
+437% +$262K ﹤0.01% 5128
2021
Q3 		$63K Buy
+520
New +$60.7K ﹤0.01% 5758
2020
Q4 		– Sell
-93
Closed -$13K – 6048
2020
Q3 		$13K Buy
+93
New +$18.8K ﹤0.01% 5231

Other funds holding BIOC

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

JP Morgan Chase's BIOC Position: Q3 2023 in Review

JP Morgan Chase sold out of Biocept, Inc. (BIOC) in Q3 2023, closing a stake of 268 shares — an estimated $324 sold.

JP Morgan Chase first reported a position in BIOC in Q3 2020 and held it in 5 quarters. The position peaked at $303K in Q4 2021. 13 funds tracked by Wall St. Rank hold BIOC as of Q3 2023.

  • JP Morgan Chase reported no remaining Biocept, Inc. position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Chase sold 268 Biocept, Inc. shares in Q3 2023, an estimated $324.
  • JP Morgan Chase first reported a position in Biocept, Inc. in Q3 2020 and held it in 5 quarters.
  • JP Morgan Chase's Biocept, Inc. position peaked at $303K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.